NASDAQ: KPTI       Karyopharm Therapeut
Last Price Today's Change   Day's Range   Trading Volume
15.06   -0.38 (2.46%)  14.825 - 15.71  1,169,904


Avg Volume (4 weeks):1,528,320
4 Weeks Range:10.34 - 15.74
4 Weeks Price Volatility (%):
52 Weeks Range:3.92 - 15.74
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Karyopharm Therapeutics Inc., is a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases. The company has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. Karyopharm’s lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications.

  Be the first to like this.


2945  2666  450  2909 

Top 10 Active Counters
 CHK 0.698+0.028 
 FCEL 0.827+0.282 
 AMD 37.45+0.74 
 ET 11.13-0.53 
 AABA 19.630.00 
 GE 11.301-0.119 
 DIS 149.025+10.445 
 BAC 32.765-0.325 
 F 8.805-0.235 
 CLVS 6.55+1.085 
Partners & Brokers